Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibiting Glucosylceramide Synthase Exacerbates Cisplatin-Induced Acute Kidney Injury

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2017English

Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional P53

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Immune Checkpoint Inhibition in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Cisplatin and Fluorouracil Alone or With Docetaxel in Head and Neck Cancer

New England Journal of Medicine
Medicine
2007English

Inhibition of Caspase-9 Activity in Cisplatin-Resistant Head and Neck Squamous Cell Carcinoma.

Journal of Otolaryngology of Japan
Otorhinolaryngology
2002English

Drosophila Glucosylceramide Synthase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2019English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy